PubMed:11009181 / 1453-1623 JSONTXT

{"project":"LitCoin-entities","denotations":[{"id":"378","span":{"begin":52,"end":63},"obj":"ChemicalEntity"},{"id":"379","span":{"begin":89,"end":108},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A22","pred":"db_id","subj":"378","obj":"MESH:D001058"},{"id":"A23","pred":"db_id","subj":"379","obj":"MESH:D010300"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Given the marked degree of efficacy of subcutaneous apomorphine treatment in fluctuating Parkinson's disease, this approach seems to deserve more widespread clinical use."}

{"project":"LitCoin-sentences","denotations":[{"id":"T9","span":{"begin":0,"end":170},"obj":"Sentence"}],"text":"Given the marked degree of efficacy of subcutaneous apomorphine treatment in fluctuating Parkinson's disease, this approach seems to deserve more widespread clinical use."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T4","span":{"begin":89,"end":108},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"0005180"}],"text":"Given the marked degree of efficacy of subcutaneous apomorphine treatment in fluctuating Parkinson's disease, this approach seems to deserve more widespread clinical use."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T20","span":{"begin":10,"end":16},"obj":"GeneOrGeneProduct"}],"text":"Given the marked degree of efficacy of subcutaneous apomorphine treatment in fluctuating Parkinson's disease, this approach seems to deserve more widespread clinical use."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T5","span":{"begin":89,"end":108},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A5","pred":"originalLabel","subj":"T5","obj":"D010300"}],"text":"Given the marked degree of efficacy of subcutaneous apomorphine treatment in fluctuating Parkinson's disease, this approach seems to deserve more widespread clinical use."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T7","span":{"begin":89,"end":108},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"0005180"}],"text":"Given the marked degree of efficacy of subcutaneous apomorphine treatment in fluctuating Parkinson's disease, this approach seems to deserve more widespread clinical use."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T6","span":{"begin":89,"end":108},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A6","pred":"ID:","subj":"T6","obj":"D010300"}],"text":"Given the marked degree of efficacy of subcutaneous apomorphine treatment in fluctuating Parkinson's disease, this approach seems to deserve more widespread clinical use."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T6","span":{"begin":89,"end":108},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A6","pred":"#label","subj":"T6","obj":"D010300"}],"text":"Given the marked degree of efficacy of subcutaneous apomorphine treatment in fluctuating Parkinson's disease, this approach seems to deserve more widespread clinical use."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T26","span":{"begin":52,"end":63},"obj":"ChemicalEntity"}],"attributes":[{"id":"A26","pred":"ID:","subj":"T26","obj":"D001058"},{"id":"A27","pred":"ID:","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_48538"}],"text":"Given the marked degree of efficacy of subcutaneous apomorphine treatment in fluctuating Parkinson's disease, this approach seems to deserve more widespread clinical use."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T26","span":{"begin":52,"end":63},"obj":"ChemicalEntity"},{"id":"T3078","span":{"begin":89,"end":108},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A27","pred":"ID:","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_48538"},{"id":"A26","pred":"ID:","subj":"T26","obj":"D001058"},{"id":"A1917","pred":"#label","subj":"T3078","obj":"D010300"}],"text":"Given the marked degree of efficacy of subcutaneous apomorphine treatment in fluctuating Parkinson's disease, this approach seems to deserve more widespread clinical use."}